Cigarette smoke and ozone effect on murine inflammatory responses

Annals of the New York Academy of Sciences

Volumn 1259, Issue 1, 2012, Pages 104-111

  Gardi, Concetta ^a   Valacchi, Giuseppe ^b,c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Kyung Hee University   (South Korea)

Author keywords

Air pollution; Lung injury; Mouse models; Oxidative stress

Indexed keywords

ALPHA 1 ANTITRYPSIN; ASCORBIC ACID; CIGARETTE SMOKE; COPPER ZINC SUPEROXIDE DISMUTASE; GAMMA INTERFERON; GELATINASE B; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; MACROPHAGE ELASTASE; MUCIN 5AC; OZONE; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; AIR POLLUTION; ARTICLE; ASTHMA; CELL DEATH; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 4; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIPID PEROXIDATION; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS;

MURINAE;

EID: 84863505966     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06605.x     Document Type: Article

References (103)

1. Brunekreef, B. & S.T. Holgate 2002. Air pollution and health. Lancet 360: 1233-1242.
2. Budinger, G.R. & G.M. Mutlu 2011. Update in environmental and occupational medicine 2010. Am. J. Respir. Crit. Care Med. 83: 1614-1619.
3. Ko, F.W. & D.S. Hui 2011. Air pollution and COPD. Respirology 17: 395-401.
4. Kelly, F.J. & J.C. Fussell 2011. Air pollution and airway disease. Clin. Exp. Allergy 41: 1059-1071.
5. Franchini, M. & P.M. Mannucci 2012. Air pollution and cardiovascular disease. Thromb. Res. 129: 230-234.
6. Ito, K. 2011. Semi-long-term mortality effects of ozone. Am. J. Respir. Crit. Care Med. 184: 754-755.
7. Viegi, G. et al 2006. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. Respirology 11: 523-532.
8. Nicita-Mauro, V. et al 2008. Smoking, aging and the centenarians. Exp. Gerontol. 43: 95-101.
9. Adcock, I.M. 2011. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 81: 265-284.
10. Mudway, I.S. & F.J. Kelly 2009. Ozone and the lung: a sensitive issue. Mol. Aspects Med. 21: 1-48.
11. Kampa, M. & E. Castanas 2008. Human health effects of air pollution. Environ. Pollut. 151: 362-367.
12. Jerrett, M. et al 2009. Long-term ozone exposure and mortality. N. Engl. J. Med. 360: 1085-1095.
13. Bhalla, D.K. 1999. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J. Toxicol. Environ. Health B. Crit. Rev. 2: 31-86.
14. Castillejos, M. et al 1992. Effects of ambient ozone on respiratory function and symptoms in Mexico City schoolchildren. Am. Rev. Respir. Dis. 145: 276-282.
15. Church, D.F. & W.A. Pryor 1985. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64: 111-126.
16. Pryor, W.A., D.G. Prier & D.F. Church 1983. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ. Health Perspect. 47: 345-355.
17. Zang, L.Y., K. Stone & W.A. Pryor 1995. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic. Biol. Med. 19: 161-167.
18. Alberg, A.J. & J.M. Samet 2003. Epidemiology of lung cancer. Chest 123: 21S-49S.
19. Sethi, J.M. & C.L. Rochester 2000. Smoking and chronic obstructive pulmonary disease. Clin. Chest Med. 21: 67-86.
20. Mannino, D.M. & A.S. Buist 2007. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773.
21. Department of Health and Human Services. 2004. The health consequences of smoking. A Report of the Surgeon General. U.S. Department of Health and Human Services, Washington, DC
22. Allender S. et al. 2008. European cardiovascular disease statistics.
23. Brennan, P. et al 2006. High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am. J. Epidemiol. 164: 1233-1241.
24. Bhalla, D.K. 2002. Interactive effects of cigarette Smoke and ozone in the induction of lung injury. Toxicol. Sci. 65: 1-3.
25. Churg, A. 2003. Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic. Biol. Med. 34: 1230-1235.
26. Yu, M., K.E. Pinkerton & H. Witschi 2002. Short-term exposure to aged and diluted sidestream cigarette smoke enhances ozone-induced lung injury in B6C3F1 mice. Toxicol. Sci. 65: 99-106.
27. March, T.H. et al 2002. Effects of concurrent ozone exposure on the pathogenesis of cigarette smoke-induced emphysema in B6C3F1 mice. Inhal. Toxicol. 14: 1187-1213.
28. Pryor, W.A., G.L. Squadrito & M. Friedman 1995. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic. Biol. Med. 19: 935-941.
29. Valacchi, G. et al 2004. In vivo ozone exposure induces antioxidant/stress-related responses in murine lung and skin. Free Radic. Biol. Med. 36: 673-681.
30. Heijink, I.H. et al 2012. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur. Respir. J. 39: 419-428.
31. Ciencewicki, J., S. Trivedi & S.R. Kleeberger 2008. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 122: 456-468.
32. Murugan, V. & M.J. Peck 2009. Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease. Exp. Lung Res. 35: 439-485.
33. Song, H., W. Tan & X. Zhang 2011. Ozone induces inflammation in bronchial epithelial cells. J. Asthma 48: 79-83.
34. Bhalla, D.K. et al 2009. Cigarette smoke, inflammation, and lung injury: a mechanistic perspective. J. Toxicol. Environ. Health 12: 45-64.
35. Cho, H.Y., L.Y. Zhang & S.R. Kleeberger 2001. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor alpha receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L537-L546.
36. Yao, H. & I. Rahman 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol. Appl. Pharmacol. 254: 72-85.
37. Chung, K.F. & I.M. Adcock 2008. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31: 1334-1356.
38. Hicks, A. et al 2010. Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents an non-human primates. Prostaglandins Other Lipid Mediat. 92: 33-43.
39. Mudway, I.S. et al 1999. Compromised concentrations of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone. Occup. Environ. Med. 56: 473-481.
40. Avissar, N.E. et al 2000. Ozone, but not nitrogen dioxide, exposure decreases glutathione peroxidases in epithelial lining fluid of human lung. Am. J. Respir. Crit. Care Med. 162: 1342-1347.
41. Rahman, I. & W. MacNee 1999. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 277: L1067-L1088.
42. Rahman, I. & I.M. Adcock 2006. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. 28: 219-242.
43. Cho, H.Y. & S.R. Kleeberger 2010. Nrf2 protects against airway disorders. Toxicol. Appl. Pharmacol. 244: 43-56.
44. Rangasamy, T. et al 2004. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114: 1248-1259.
45. Iizuka, T. et al 2005. Nrf2-deficient mice are highly susceptible to cigarette smoke induced emphysema. Genes Cells. 10: 1113-1125.
46. Cho, H.Y. et al 2005. Gene expression profiling of Nrf2-mediated protection against oxidative injury. Free Radic. Biol. Med. 38: 325-343.
47. Annesi-Maesano, I. et al 2003. Subpopulations at increased risk of adverse health outcomes from air pollution. Eur. Respir. J. 40: 57-63.
48. Gauderman, W.J. et al 2004. The effect of air pollution on lung development from 10 to 18 years of age. N. Engl. J. Med. 351: 1057-1067.
49. Holz, O. et al 1999. Ozone-induced airway inflammatory changes differ between individuals and are reproducible. Am. J. Respir. Crit. Care Med. 159: 776-784.
50. Fletcher, C. 1977. The natural history of chronic airflow obstruction. Br. Med. J. 1: 1645-1648.
51. Salvi, S.S. & P.J. Barnes 2009. Chronic obstructive pulmonary disease in non-smokers. Lancet. 374: 733-743.
52. Valacchi, G. et al 2007. Lung vitamin E transport processes are affected by both age and environmental oxidants in mice. Toxicol. Appl. Pharmacol. 222: 227-234.
53. Sullivan, J.B. & G.R. Krieger, eds. 2001. Clinical Environmental Health and Toxic Exposure. Lippincott Williams and Wilkins, Philadelphia, PA
54. Kleeberger, S.R. 2003. Genetic aspects of susceptibility to air pollution. Eur. Respir. J. 40: 52-56.
55. Kleeberger, S.R. 2005. Genetic aspects of pulmonary responses to inhaled pollutants. Exp. Toxicol. Pathol. 57: 147-153.
56. Yao, H. et al 2008. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1174-1186.
57. Guerassimov, A. 2004. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170: 974-980.
58. Vecchio, D. et al 2010. Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L704-L713.
59. Bauer, A.K. & S.R. Kleeberger 2010. Genetic mechanisms of susceptibility to ozone-induced lung disease. Ann. N.Y. Acad. Sci. 1203: 113-119.
60. Cho, H.Y. & S.R. Kleeberger 2007. Genetic mechanisms of susceptibility to oxidative lung injury in mice. Free Radic. Biol. Med. 42: 433-445.
61. Savov, J.D. et al 2004. Ozone-induced acute pulmonary injury in inbred mouse strains. Am. J. Respir. Cell Mol. Biol. 31: 69-77.
62. Young, R.P. et al 2006. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax. 61: 394-399.
63. Sandford, A.J. et al 2001. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Respir. Crit. Care Med. 163: 469-473.
64. Kucukaycan, M. et al 2002. Tumor necrosis factor-alpha +489 G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir. Res. 3: 29-35.
65. Celedon, J.C. et al 2004. The transforming growth factor-beta1 (TGFb1)gene is associated with chronic obstructive pulmonary disease (COPD). Hum. Mol. Genet. 13: 1649-1656.
66. Bartalesi, B. et al 2005. Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur. Respir. J. 25: 15-22.
67. 1-proteinase inhibitor and sensitivity to oxidants. Am. J. Respir. Crit. Care Med. 164: 886-890.
68. Martorana, P.A. et al 2006. Models for COPD involving cigarette smoke. Drug Discov. Today Dis. Models 3: 225-230.
69. March, T.H. et al 1999. Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 mice than in F344 rats. Toxicol. Sci. 51: 289-299.
70. Hautamaki, R.D. et al 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
71. Cavarra, E. et al 2001. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L412-L417.
72. Rahman, I. 2012. Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim. Biophys. Acta 1822: 714-728.
73. Morris, D.G. et al 2003. Loss of integrin avb6-mediated TGF-b activation causes MMP12-dependent emphysema. Nature 422: 169-173.
74. Shapiro, S.D. 1994. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med. 150: S160-S164.
75. Hoshino, T. et al 2007. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am. J. Respir. Crit. Care Med. 176: 49-62.
76. Zheng, T. et al 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 106: 1081-1093.
77. Wang, Z. et al 2000. Interferon-g induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192: 1587-1600.
78. Kang, M.J. et al 2007. IL-18 is induced and IL-18 receptor a plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J. Immunol. 178: 1948-1959.
79. Churg, A. et al 2004. Tumor necrosis factor-a drives 70% of cigarette smoke induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 170: 492-498.
80. Rangasamy, T. et al 2009. Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L888-L900.
81. Reddy, N.M. et al 2007. Deficiency in Nrf2-GSH signaling impairs type II cell growth and enhances sensitivity to oxidants. Am. J. Respir. Cell. Mol. Biol. 37: 3-8.
82. Sussan, T.E. et al 2009. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc. Natl. Acad. Sci. USA 106: 250-255.
83. Cho, H.Y. et al 2002. Linkage analysis of susceptibility to hyperoxia. Am. J. Respir. Cell Mol. Biol. 26: C42-C51.
84. Li, N. & A.E Nel 2006. Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma. Antioxid. Redox Signal. 8: 88-98.
85. Foronjy, R.F. et al 2006. Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am. J. Respir. Crit. Care Med. 173: 623-631.
86. Wesselkamper, S.C. et al 2000. Genetic susceptibility to irritant-induced acute lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L575-L582.
87. Triantaphyllopoulos, K. et al 2011. A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 300: L691-L700.
88. Williams, A.S. et al 2008. Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13. Eur. Respir. J. 32: 571-578.
89. Katre, A. et al 2011. Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice. Inhal. Toxicol. 23: 486-494.
90. Prows, D.R. et al 1997. Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat. Genet. 17: 471-474.
91. Prows, D.R. et al 1999. Ozone-induced acute lung injury:genetic analysis of F2 mice generated from A/J and C57BL/6J strains. Am. J. Physiol. 277: L372-L380.
92. Kleeberger, S.R. et al 1997. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat. Genet. 17: 475-478.
93. Cho, H.Y. et al 2007. Signal transduction pathways of tumor necrosis factor-mediated lung injury induced by ozone. Am. J. Respir. Crit. Med. 15: 829-839.
94. Nicholas, J. et al 2002. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L540-L545.
95. Morris, G.E. et al 2006. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J. 20: 2153-2155.
96. Poltorak, A. et al 1998. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in the Tlr4 gene. Science 282: 2085-2088.
97. Qureshi, S.T. et al 1999. Endotoxin intolerant mice have mutations in toll-like receptor 4 (Tlr4). J. Exp. Med. 189: 615-625.
98. Kleeberger, S.R. et al 2000. Genetic susceptibility to ozone-induced lung hyperpermeability. Role of toll-like receptor 4. Am. J. Respir. Cell Mol. Biol. 22: 620-627.
99. Cho, H.Y. et al 2002. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26: 175-182.
100. Rangasamy, T. et al 2005. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202: 47-59.
101. Sticozzi, C. & G. Valacchi 2011. Troposphere ozone as a source of oxidative stress in cutaneous tissues. J. Sci. Ind. Res. 70: 918-922.
102. McCreanor, J. et al 2007. Respiratory effects of exposure to diesel traffic in persons with asthma. N. Engl. J. Med. 357: 2348-58.
103. Adewole, F. et al 2009. Diesel exhaust causing low-dose irritant asthma with latency? Occup. Med. (Lond). 59: 424-427.